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In spindle assembly checkpoint (SAC)
signaling, the phospho-amino acid
adaptor Bub3 forms complexes with
Bub1 and BubR1 paralogs. Whether
Bub3-Bub1 and Bub3-BubR1 bind
distinct targets has been unclear.
Overlack et al. demonstrate that this is the
case and identify a motif in BubR1 that
directs Bub3 to the SAC target, the
anaphase-promoting complex..
Current Biology
ArticleBubR1 Promotes Bub3-Dependent APC/C Inhibition
during Spindle Assembly Checkpoint Signaling
Katharina Overlack,1 Tanja Bange,1 Florian Weissmann,3 Alex C. Faesen,1 Stefano Maffini,1 Ivana Primorac,1,4
Franziska Mu¨ller,1 Jan-Michael Peters,3 and Andrea Musacchio1,2,5,*
1Department of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany
2Centre for Medical Biotechnology, Faculty of Biology, University Duisburg-Essen, Universit€atsstrasse, 45141 Essen, Germany
3Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Campus-Vienna-Biocenter 1, 1030 Vienna, Austria





The spindle assembly checkpoint (SAC) prevents
premature sister chromatid separation during
mitosis. Phosphorylation of unattached kineto-
chores by the Mps1 kinase promotes recruitment of
SAC machinery that catalyzes assembly of the SAC
effector mitotic checkpoint complex (MCC). The
SAC protein Bub3 is a phospho-amino acid adaptor
that forms structurally related stable complexes
with functionally distinct paralogs named Bub1 and
BubR1. A short motif (‘‘loop’’) of Bub1, but not the
equivalent loop of BubR1, enhances binding of
Bub3 to kinetochore phospho-targets. Here, we
asked whether the BubR1 loop directs Bub3 to
different phospho-targets. The BubR1 loop is essen-
tial for SAC function and cannot be removed or re-
placed with the Bub1 loop. BubR1 loop mutants
bind Bub3 and are normally incorporated in MCC
in vitro but have reduced ability to inhibit the MCC
target anaphase-promoting complex (APC/C), sug-
gesting that BubR1:Bub3 recognition and inhibition
of APC/C requires phosphorylation. Thus, small
sequence differences in Bub1 and BubR1 direct
Bub3 to different phosphorylated targets in the
SAC signaling cascade.
INTRODUCTION
Bub1 and BubR1 (also known as Mad3 in certain organisms) are
paralogous proteins that fulfill different crucial functions in chro-
mosome alignment on the mitotic spindle and in the spindle
assembly checkpoint (SAC), a safety mechanism that ensures
accurate chromosome segregation during mitosis [1, 2]. Bub1
and BubR1 originated through multiple independent gene-dupli-
cation events from a precursor (singleton) surmised to be already
present in the hypothetical last eukaryotic common ancestor
(LECA). Gene duplication invariably led to sub-functionalization
of the resulting gene products [3, 4] (Figure 1A).Current Biology 27, 2915–2927, Octo
This is an open access article under the CC BY-NThe molecular mechanism subtending to sub-functionaliza-
tion of Bub1 and BubR1 is an active area of research. Bub1 is
a Ser/Thr kinase [8] whose kinase activitymay be strictly required
for chromosome alignment, but not for SAC signaling [9–17].
Bub1 localizes to kinetochores in early prometaphase and is
thought to perform itsmain role in the SACby acting as a scaffold
for the recruitment of downstream checkpoint components,
including Mad1, Mad2, BubR1, Bub3, and Cdc20 [11, 14,
18–28]. Bub1 promotes the incorporation of a subset of these
proteins, including BubR1, Bub3, Mad2, and Cdc20, into the
mitotic checkpoint complex (MCC), the main checkpoint
effector, which directly inhibits the ability of the E3 ubiquitin
ligase anaphase-promoting complex/cyclosome (APC/C) to
promote exit from mitosis [1, 2]. Promotion of MCC formation
by Bub1 likely occurs through a direct interaction with a
Mad1:Mad2 template that catalyzes MCC assembly [11, 29–35].
Unlike Bub1, BubR1 is an inactive pseudokinase [4]. It contrib-
utes directly to the SAC and to APC/C inhibition as a subunit of
the MCC (together with Bub3, Cdc20, and Mad2) [36–38]. Two
Lys-Glu-Asn (KEN) motifs (also called KEN boxes) in the N-termi-
nal region of BubR1 have been implicated in Cdc20 binding and
APC/C inhibition. The first KEN box is essential for stable incor-
poration of BubR1 in a complex with Cdc20 and Mad2 that rep-
resents the core of the MCC [39–43]. The second KEN box
promotes binding to a second Cdc20 molecule, possibly when
the latter is already bound to the APC/C [44–47]. Both KEN
motifs are required for effective APC/C inhibition and SAC func-
tion (e.g., see [42]). In addition to its role in SAC activation,
BubR1 also contributes to the formation of stable kinetochore-
microtubule interactions and SAC silencing through kinetochore
recruitment of the phosphatase PP2AB56 [48–52].
In human cells, kinetochore localization of Bub1 and BubR1
requires phosphorylation by the SAC kinase Mps1 of so-called
Met-Glu-Leu-Thr (MELT) motifs in the outer kinetochore protein
Knl1 (also known as Spc105, Spc7, and Casc5) [53–55]. It also
requires binding to Bub3, which acts as a targeting adaptor
[40, 42, 56–58]. Bub1 and BubR1 bind to Bub3 via conserved
Bub3-binding domains (B3BD or GLEBS; Figure 1A) [57, 59].
Bub3, a seven-bladed b propeller, contains an evolutionarily
conserved binding pocket that accommodates the phosphory-
lated Thr residue of the MELT motifs (Figures 1B, S1A, and









Figure 1. Kinetochore Localization and Turnover of Long BubR1 Loop Mutants in HeLa Cells
(A) Schematic overview of Bub1 and BubR1 domain organization. B1, Bub1; B3BD, Bub3 binding domain; BR1, BubR1; KEN, lysine-glutamate-asparaginemotif;
TPR, tetratrico peptide repeat.
(B) Schematic depiction of the outer kinetochore (KMN network). MELT repeats in Knl1 are phosphorylated by the checkpoint kinase Mps1 and recruit
Bub1:Bub3. Bub1:Bub3 in turn recruits BubR1:Bub3 via a pseudo-symmetric interaction, which involves equivalent segments of Bub1 and BubR1 comprising the
B3BD and the C-terminal extension whose first part is predicted to form a helix in both proteins. The presence of Bub3 on both proteins seems to be essential for
this interaction. The TPR regions of human Bub1 and BubR1 bind to non-conserved short motifs of Knl1 named KI1 and KI2, respectively [5–7].
(legend continued on next page)
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for kinetochore localization in the absence of other Bub1 regions
[5, 57]. We recently reported that a short region of the B3BD of
Bub1, which we designated as the ‘‘loop’’ (Figures 1C, S1A,
and S1B), markedly increases the binding affinity of Bub3 for
phosphorylated MELT motifs (MELTP) through direct contacts
[58, 60]. The loop region in the B3BD of BubR1, on the other
hand, is unable to increase the binding affinity of Bub3 for
Knl1-MELTP sequences, rendering kinetochore localization of
BubR1:Bub3 dependent on additional interactions [5, 60].We re-
ported that kinetochore-bound Bub1:Bub3 provides these addi-
tional interactions [60], thus establishing a clear hierarchy in
which Bub1:Bub3 is first directly recruited to the kinetochore
via interaction with MELTP motifs, after which BubR1:Bub3 is
recruited through a direct interaction with Bub1 (Figure 1B).
This model agrees with observations that kinetochore recruit-
ment of Bub1 is independent of BubR1, whereas kinetochore
localization of BubR1 depends on Bub1 [11, 12, 21, 56, 60–63].
Hetero-dimerization of Bub1:Bub3 and BubR1:Bub3 requires
equivalent domains in Bub1 and BubR1, including the B3BD
and a region, directly following the B3BD, predicted to adopt
helical conformation. Furthermore, both proteins need to be
bound to Bub3 for their effective recruitment to kinetochores
(Figure 1B) [60].
The crucial role of the Bub1 loop as enhancer of MELTP bind-
ing was emphasized by the fact that grafting the Bub1 loop onto
BubR1 promoted Bub1-independent kinetochore recruitment of
BubR1 [60]. The observation that this loop swap mutant,
however, was unable to support BubR1 SAC function [60] raised
the question whether the BubR1 loop performs a specific and so
far unidentified function. In this study, we set out to investigate
the role of the BubR1 loop in more detail. We demonstrate
that the BubR1 loop promotes stable association of the MCC
complex with the APC/C.
RESULTS
Definition of Functional Loop Regions of Bub1 and
BubR1
The B3BD of Bub1 is sufficient for kinetochore recruitment
through Bub3 [5, 57, 60]. In our previous studies, we identified
the Bub1 loop region (Bub1L) (residues 214–226 within the
Bub1B3BD; Figures 1A and 1C) as a determinant of kinetochore
localization of the Bub1:Bub3 complex and showed that Bub1L
enhances the affinity of the interaction of Bub3 for Knl1-MELTP
motifs at kinetochores [60]. We also showed that, when grafted
onto BubR1, Bub1L promotes Bub1-independent kinetochore(C) Multiple sequence alignments of the B3BDs of Bub1 and BubR1 from four diff
Saccharomyces cerevisiae. Mad3 is the budding yeast BubR1 homolog. The init
numbers are indicated in the main text.
(D) Domain organization of the BubR1 constructs with the Bub1 loop. BubR1B1-L c
(E) Representative images of HeLa cells transfected with the indicated GFP-Bub
than the short loop mutant (B1-L) in presence and absence of endogenous Bub1
synchronized with a double thymidine block, and arrested in mitosis with nocod
(F) Quantification of BubR1 kinetochore levels in cells treated as in (E). The graph s
SEM. Values for BubR1wt in non-depleted cells are set to 1.
(G–J) FRAP analyses of GFP-tagged BubR1wt (G), BubR1B1-LL (H and I), and GF
(I and J). Relevant recovery parameters are shown. The graphs showmean with S
localization of each construct.
See also Figures S1–S3.recruitment of BubR1. This result agreed with observations
in vitro that the equivalent BubR1 loop region (BubR1L) (residues
368–379) is unable to promote the interaction of Bub3 with
Knl1-MELTP motifs and is therefore functionally distinct from
Bub1L [60].
As clarified in Figure S2 (and legend), we discovered that graft-
ing onto BubR1 longer regions of Bub1 (residues 209–235),
ranging from the first b sheet (b1) until the beginning of the highly
conserved core of the B3BD (Figures 1C and 1D), resulted in
more robust kinetochore localization in comparison to that of
BubR1B1-L, especially after depletion of endogenous Bub1 (Fig-
ures 1E and 1F; to differentiate this longer sequence from that of
Bub1L, we denote it as ‘‘long loop’’ [Bub1LL]). BubR11–431/B1-LL,
which lacks the predicted helical region required for dimerization
with Bub1, localized to kinetochores in presence or absence of
endogenous Bub1 (Figures S2E and S2F). Thus, the Bub1LL
region is sufficient to mediate kinetochore localization when
grafted on a dimerization-deficient BubR1 mutant. When we
grafted the equivalent region of BubR1 (residues 363–396;
BubR1LL) onto Bub1 (Bub1BR1-LL), we observed that it impaired
kinetochore localization of Bub1 significantly more pervasively
than when grafting the shorter BubR1L sequence (Bub1BR1-L)
(Figures S2G and S2H). Collectively, these experiments identify
the LL regions of Bub1 and BubR1 as crucial determinants of
their localization and demonstrate that these sequences impart
substantial functional divergence to the Bub1 and BubR1
paralogs.
Kinetochore Turnover of BubR1 Loop Mutants
We investigated the effects of grafting Bub1LL on BubR1 kineto-
chore turnover. The halftime of kinetochore localization of BubR1
measured by fluorescence recovery after photobleaching
(FRAP) is relatively fast (t1/2 = 3–20 s) [64, 65]. This rapid turnover
of BubR1 likely reflects its dimerization with kinetochore Bub1
and subsequent release, possibly in complex with other MCC
subunits. In agreement with the published data [64], we found
in FRAP experiments in HeLa cells depleted of endogenous
BubR1 that GFP-BubR1WT showed a recovery halftime of 7.7 s
(fit with a single exponential curve; Figure 1G; Table S1; the
cartoon beside the graph depicts the expected mode of kineto-
chore localization of the construct).
If grafting of Bub1LL allows BubR1B1-LL to interact with MELTP
in addition to dimerizing with Bub1, substantial increases of its
kinetochore residence time might be expected if the two binding
modes occurred concomitantly. FRAP curves of the GFP-
BubR1B1-LL mutant were best fitted with a double exponentialerent species: Hs, Homo sapiens; Gg,Gallus gallus; Xl, Xenopus laevis; and Sc,
ial loop (L) and the long loop (LL) are indicated by the red lines; exact residue
ontains Bub1 residues 214–226; BubR1B1-LL contains Bub1 residues 209–235.
R1 constructs showing that GFP-BubR1B1-LL localizes better to kinetochores
. In brief, after transfection, cells were depleted of endogenous Bub1 by RNAi,
azole. The scale bar represents 10 mm.
howsmean intensity from three independent experiments. Error bars represent
P-Bub1wt in absence of endogenous BubR1 (G and H) or endogenous Bub1
EM. The cartoons beside the graphs depict the expected mode of kinetochore
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curve (Figure 1H; Table S1). A minority of GFP-BubR1B1-LL
(15.5%) turned over with a halftime of 5.2 s, likely reflecting single
binding events (dimerization with Bub1 or direct binding to
MELTP sequences). The majority of GFP-BubR1B1-LL, on the
other hand, cycled with a halftime of 56.4 s, indeed suggesting
the possibility that the two kinetochore-binding modes, namely
the dimerization with Bub1 and the direct interaction of GFP-
BubR1B1-LL with MELTP, occur concomitantly and strongly sta-
bilize GFP-BubR1B1-LL at kinetochores. GFP-BubR1LL showed
higher kinetochore levels than GFP-BubR1WT in cells depleted
of endogenous BubR1 (Figures S3A and S3B), as expected
given its increased halftime. We note that this is compatible
with previous studies showing that only a subset of all MELTP
motifs of Knl1 are occupied with Bub1 at any given time [66].
This binding model predicts that depletion of endogenous
Bub1 will ablate dimerization, only allowing a single binding
mode of GFP-BubR1B1-LL through MELTP binding. In agree-
ment with this hypothesis, depletion of endogenous Bub1 by
RNAi resulted in a recovery curve for GFP-BubR1B1-LL that
could be fitted with a single exponential function with rapid
turnover (t1/2 = 10.8 s; Figure 1I; Table S1). Like BubR1
B1-LL,
also Bub1 interacts with kinetochores by binding MELTP se-
quences, and therefore, it is expected to turn over at kineto-
chores with a similarly rapid halftime. Whereas previous
studies reported that Bub1 turns over relatively slowly at kinet-
ochores [64, 65], our measurements indicate rapid kinetochore
turnover of GFP-Bub1WT (t1/2 = 11.6 s; Figure 1J; Table S1),
very similar to the recovery halftime of GFP-BubR1B1-LL after
Bub1 depletion. Our observations are corroborated by a recent
study reporting a recovery halftime of 15 s for kinetochore
Bub1 [67].
The Bub1 Loop Cannot Promote the SAC Function of
BubR1 In Vivo
Next, we asked whether BubR1B1-LL was able to rescue SAC
signaling in HeLa cells depleted of endogenous BubR1.
A BubR1 alanine mutant in the first KEN box (KEN1; Figure 2A)
was used as a control for checkpoint deficiency in these exper-
iments [42]. Asynchronous cells entering mitosis in presence of
low concentrations of the spindle poison nocodazole arrested
robustly in mitosis for several hours, indicative of SAC activation
(Figure 2B). Depletion of BubR1 prevented mitotic arrest but
could be rescued by expression of a wild-type GFP-BubR1
transgene. On the other hand, BubR1B1-LL was unable to rescue
the deleterious effects on the SAC caused by depletion of
endogenous BubR1 to an extent similar to that of the KEN1
boxmutant (Figure 2B). Thus, the Bub1LL region cannot function-
ally replace the equivalent region of BubR1. These findings were
corroborated by immunoprecipitation experiments (IPs) of the
GFP-BubR1 species, followed bywestern blotting (WB) to detect
MCC and APC/C subunits. This revealed a substantial decrease
in the association of GFP-BubR1B1-LL or GFP-BubR1KEN1/AAA
with Mad2 and Cdc20 (but not Bub3, as expected) as well
as the APC/C subunits Cdc27, Apc7, and Apc4 (Figure 2C;
quantified in Figure S4A). Similar results were obtained when
we replaced the sequence of the BubR1 loop with a neutral
Gly-Ser-linker sequence (Figures S5A–S5D).
As explained in the previous section, data in Figures 1G–1J
suggest that GFP-BubR1B1-LL dimerizes with Bub1 and also2918 Current Biology 27, 2915–2927, October 9, 2017binds to phosphorylated MELT motifs at kinetochores. We
hypothesized that the SAC defect following grafting of the
Bub1LL region into BubR1 might be caused by increased kineto-
chore residence of this mutant, which also reflected in a strongly
increased interaction with the Knl1 kinetochore receptor (Fig-
ure S4A). If rapid kinetochore turnover of BubR1 is required for
its efficient incorporation into MCC, tighter kinetochore binding
might counteract incorporation into MCC. We therefore asked
whether we could rescue the SAC deficiency of the GFP-
BubR1B1-LL mutant by restoring rapid kinetochore turnover.
To test this hypothesis, we designed two constructs expected
to reduce the time of kinetochore residence of GFP-BubR1B1-LL
(see Figure 2A for schematics). First, we combined grafting of the
Bub1LL region with deletion of the predicted helical region (resi-
dues 432–484) involved in BubR1 dimerization with Bub1 (desig-
nated as GFP-BubR1B1-LL/DH). GFP-BubR1B1-LL/DH is expected
to localize correctly but exclusively through Bub1LL-mediated
recognition of MELTP and not through dimerization. Importantly,
deletion of the BubR1 helical region is fully compatible with
SAC signaling (see next paragraph). Second, we grafted the
entire B3BD and helical region of Bub1 onto GFP-BubR1
(GFP-BubR1B1-B3BD/B1-H), thus again forcing BubR1 to interact
with kinetochores exclusively through MELTP and not through
an interaction with Bub1 (because neither Bub1 nor BubR1 can
form homodimers).
In agreement with our expectations, and more generally with
our model of kinetochore recruitment of Bub1 and BubR1,
both GFP-BubR1B1-B3BD/B1-H and GFP-BubR1B1-LL/DH showed
robust localization to kinetochores (Figures S4B and S4C), and
FRAP analyses of both mutants demonstrated rapid kinetochore
turnover (Figures 2D and 2E), with recovery halftimes that were
essentially indistinguishable from those of GFP-BubR1WT (Fig-
ure 1G; Table S1). Despite normal kinetochore turnover, how-
ever, GFP-BubR1B1-LL/DH was unable to rescue the SAC defect
caused by BubR1 depletion (Figure 2F) andwas correspondingly
unable to form stable complexes with MCC and APC/C subunits
in IP experiments (Figure 2G; quantified in Figure S4D). Impor-
tantly, GFP-BubR1DH is fully SAC proficient (Figure S4E) [60],
strongly suggesting that the SAC defect is caused by Bub1LL
grafting. Also, GFP-BubR1B1-B3BD/B1-H was unable to rescue
the SAC in cells depleted of endogenous BubR1 (Figure S4F).
In non-depleted cells, GFP-BubR1B1-B3BD/B1-H interacted with
BubR1 as expected, but its interaction with MCC and APC/C
subunits was reduced (Figure S4G). Collectively, these results
indicate that the SAC defect introduced by grafting the Bub1LL
region in GFP-BubR1B1-LL is not due to increased kinetochore
residency of this mutant.
The BubR1 Loop Is Required for SAC Function In Vivo
As an alternative explanation for why GFP-BubR1B1-LL is SAC
defective, we considered the hypothesis that the substitution
of the BubR1LL region with the Bub1LL region may interfere
with the interaction of the BubR1:Bub3 complex with a crucial
SAC target. To test this idea, we created two additional BubR1
mutants in which parts of the loop region were deleted (DL and
DLL mutant, corresponding to deletions of residues 368–379
and 363–396, respectively; Figure 3A). GFP-BubR1DL and
GFP-BubR1DLL localized to kinetochores at levels that







Figure 2. The Bub1 Loop Cannot Promote the SAC Function of BubR1 In Vivo
(A) Domain organization of the BubR1 constructs.
(B and F) Mean duration of mitosis of Flp-In T-REx stable cell lines expressing the indicated GFP-BubR1 constructs in the absence of endogenous BubR1 and in
the presence of 50 nM nocodazole. Cell morphology was used to measure entry into and exit from mitosis by time-lapse microscopy (n > 23 for BubR1B1-LL and
BubR1KEN1/AAA [B]; n > 37 for BubR1B1-LL/DH [F] per cell line per experiment) from three independent experiments. Error bars depict SEM.
(C and G) Western blot of immunoprecipitates (IPs) from mitotic Flp-In T-REx cell lines expressing the indicated GFP-BubR1 constructs (BubR1B1-LL and
BubR1KEN1/AAA [C]; BubR1B1-LL/DH [G])showing that the replacement of the BubR1 loop with the Bub1 loop results in strongly impaired APC/C binding. Tubulin
was used as loading control.
(D and E) FRAP analyses of GFP-tagged BubR1B1-B3BD/B1-H (D) and BubR1B1-LL/DH (E) in absence of endogenous BubR1. Relevant recovery parameters are
shown. The graphs show mean and SD. The cartoons beside the graphs depict the expected mode of kinetochore localization of each construct.
See also Figures S4 and S5 and Table S1.localization depended on Bub1 (Figures 3B and 3C). In FRAP ex-
periments, GFP-BubR1DLL appeared to have a recovery halftime
of 9.9 s (Figure 3D; Table S1), essentially identical to that of GFP-
BubR1WT (Figure 1G). These observations are consistent withour model that the BubR1 loop region is not required for kineto-
chore recruitment [60] (and this study).
Next, we asked whether GFP-BubR1DL and GFP-BubR1DLL





Figure 3. The BubR1 Loop Is Required for
SAC Function In Vivo
(A) Domain organization of the BubR1 constructs
used. Constructs lacking the short (L) and long loop
(LL) versions were created by deleting residues
368–379 or 363–396 of BubR1, respectively.
(B) Representative images of HeLa cells trans-
fected with the indicated GFP-BubR1 constructs
in presence or absence of endogenous Bub1,
showing that the lack of the loop does not influence
kinetochore localization, as expected. Cells were
treated as in Figure 1E. The scale bar represents
10 mm.
(C) Quantification of BubR1 kinetochore levels in
cells treated as in (B). The graph shows mean in-
tensity from three independent experiments. Error
bars represent SEM. Values for BubR1wt in non-
depleted cells are set to 1.
(D) FRAP analysis of BubR1DLL in the absence of
endogenous BubR1. Relevant recovery parame-
ters are shown. The graph shows mean and SD.
The cartoon depicts the expected mode of kinet-
ochore localization of the construct.
(E) Mean duration of mitosis of Flp-In T-REx stable
cell lines expressing the indicated GFP-BubR1
constructs in the absence of endogenous BubR1
and in the presence of 50 nM nocodazole. Cell
morphology was used to measure entry into
and exit from mitosis by time-lapse microscopy
(n > 32 for BubR1D(L)L per cell line per experiment)
from two independent experiments. Error bars
depict SEM.
(F)Western blot of IPs frommitotic Flp-In T-REx cell
lines expressing the indicated GFP-BubR1 con-
structs showing that the lack of the BubR1 loop
results in strongly impaired APC/C binding. Vinculin
was used as loading control.
See also Figure S4 and Table S1.BubR1. Both mutants were largely unable to restore the SAC
function of BubR1 (Figure 3E). Furthermore, when we com-
bined deletion of the loop with deletion of the helical region
(GFP-BubR1DL/DH; Figure S4H), we observed impairment of
the SAC (Figure S4E), accompanied by reduced interaction
with the APC/C (Figure S4I). In IP experiments, GFP-BubR1DL
and GFP-BubR1DLL were shown to bind to the MCC subunits
Mad2 and Cdc20, although at reduced levels in comparison to
GFP-BubR1WT, but were also largely impaired in their ability
to interact with the APC/C, likely explaining why these mu-
tants cannot support the SAC (Figure 3F; quantified in
Figure S4J).2920 Current Biology 27, 2915–2927, October 9, 2017The BubR1 Loop Promotes APC/C
Binding
Collectively, these observations support
the idea that the loop region of BubR1 is
required for the recognition of crucial
SAC target(s). To identify these targets,
we used the SILAC (stable isotope label-
ing with amino acids in cell culture) [68]
approach to perform quantitative IP and
mass spectrometry identification of pro-
teins bound to minimal reporter con-structs in mitotic lysates of HeLa cells. Because the B3BD of
Bub1 is sufficient for Bub3 binding and for recognition of Knl1-
MELTP repeats [60], we started our analysis with a construct cor-
responding to GFP-BubR1B3BD (residues 362–431). We found
that several of the APC/C subunits (blue squares, Figure 4A)
were specifically enriched in the GFP-BubR1B3BD precipitates
in comparison to those in the GFP control. We validated these
interactions by western blotting against the APC/C subunits
Cdc27/Apc3, Apc7, and Apc4 on GFP-BubR1B3BD precipitates
(Figure 4B). In reciprocal IP experiments, we detected GFP-





Figure 4. The BubR1 Loop Promotes APC/C
Binding
(A and C) Volcano plot showing the results
from three independent SILAC experiments using
GFP and GFP-BubR1B3BD (residues 362–431) (A)
or GFP-BubR1B3BD DL and GFP-BubR1B3BD (C) as
affinity resins to identify specific interaction part-
ners in mitotic lysates showing that the BubR1
B3BD binds to the APC/C and that this depends on
the BubR1 loop. A p value of 0.05 and 0.1 was used
as cutoff for significance, respectively.
(B and D) Western blot of IPs from mitotic Flp-In
T-REx cell lines expressing the indicated GFP-
BubR1 constructs showing that the B3BD of
BubR1 is able to pull down APC/C subunits (B)
and that this interaction is impaired if the loop is
deleted (D). Tubulin was used as loading control.
(E and F) Volcano plot showing the results from
two (E) or three (F) independent SILAC experiments
using GFP-Bub1B3BD (residues 209–270) and
GFP-BubR1B3BD (E) or GFP-Bub11–284 and GFP-
BubR11–431 (F) as affinity resins to identify specific
interaction partners in mitotic lysates, showing that
the BubR1 N-terminal region increases the speci-
ficity of the BubR1-APC/C interaction. A p value of
0.05 was used as cutoff for significance.
See also Figures S6 and S7.Next, we compared the interactome of GFP-BubR1B3BD with
and without the loop region (Figure 4C). This showed that
APC/C was enriched in precipitates of intact GFP-BubR1B3BD,
indicating that the loop promotes binding of the APC/C (Fig-
ure 4C). The role of the BubR1 loop on APC/C binding was reca-
pitulated in a GFP-IP experiment followed by western blotting
(Figure 4D; quantified in Figure S6B). Collectively, these results
indicate that the BubR1 loop promotes an interaction of the
GFP-BubR1B3BD:Bub3 complex with the APC/C.
Our results also indicate that the B3BDs of Bub1 and BubR1
direct Bub3 to Knl1 and the APC/C, respectively. To corroborate
this idea, we compared precipitates of GFP-Bub1B3BD (residues
209–270) and GFP-BubR1B3BD in another SILAC experiment
(Figure 4E). In agreement with the hypothesis, Knl1 was clearly
enriched in precipitates of GFP-Bub1B3BD. On the other hand,
we did not observe an enrichment of APC/C subunits with
GFP-BubR1B3BD in comparison to GFP-Bub1B3BD. Instead, we
found APC/C subunits to be strongly enriched in precipitates of
both constructs (and therefore appearing in the middle of the
volcano plot, together with Bub3). This result suggests that the
B3BD of Bub1 can, in principle, interact both with Knl1 and with
the APC/C, whereas that of BubR1 can only bind the APC/C.Current BioBased on these observations, we asked
whether the presence of longer segments
of Bub1 and BubR1 would increase the
selectivity for these substrates. GFP-
Bub11–284 and GFP-BubR11–431 encom-
pass the entire N-terminal region in addi-
tion to the B3BD, including the TPR
repeats and, in case of BubR1, also its
two KEN boxes, the first of which is essen-
tial for binding to Cdc20 and thereforeincorporation into the MCC [42] (Figure 1A). In SILAC IP experi-
ments, we observed that GFP-Bub11–284 and GFP-BubR11–431
have exquisite specificity for Knl1 and the APC/C, respectively.
Furthermore, we also detected Mad2 and Cdc20 in the
BubR11–431 IPs, likely because this BubR1 segment, which con-
tains the KEN boxes, is sufficient for an interaction with these
MCC subunits (Figure 4F). Thus, the selectivity of BubR1 for
the APC/C results from a combination of factors, including, in
addition to the KEN boxes, the BubR1 loop as a direct APC/C
binder. This was further confirmed by examining IPs of con-
structs in which only the loop regions were swapped. GFP-
Bub1BR1-LL and GFP-BubR1B1-LL were both unable to interact
effectively with the APC/C (Figure S7A).
TheBubR1 Loop Is Required for APC/C Inhibition In Vitro
We expressed recombinant versions of Bub3 complexes of a
BubR1 segment (residues 1–571) that is larger than the minimal
segment of BubR1 that can restore SAC function in BubR1-
depleted cells [42, 69]. In the same scaffold, we also created
the chimeric mutants BubR1B1-LL and BubR1DLL. We then puri-
fied the resulting protein complexes to homogeneity. In isolation,
BubR1WT:Bub3, BubR1B1-LL:Bub3, and BubR1DLL:Bub3 sharedlogy 27, 2915–2927, October 9, 2017 2921
AB
Figure 5. The BubR1 Loop Is Required for APC/C Inhibition In Vitro
(A) BubR1wt:Bub3 as well as the two loop mutants BubR1B1-LL:Bub3 and
BubR1DLL:Bub3 interact in size exclusion chromatography with the other two
MCC components Cdc20 and Mad2. In the chromatogram, the height of
elution curves for the three different MCC complexes were rescaled to match
that of MCC containing BubR1DLL, which emphasizes the remarkable similarity
of the elution profiles, an indication that the different MCC complexes are
structurally stable and virtually identical. Vertical dashed lines indicate the
elution volumes of the individual constituents of the three MCC complexes.
The corresponding elution profiles and SDS-PAGE analyses are shown in
Figure S7B.
(B) Ubiquitination reactions in the presence of recombinant APC/C-pE (car-
rying 68 phospho-mimicking mutations) [70] and the fluorescently labeled
N-terminal domain of cyclin B were analyzed by SDS-PAGE and fluorescence
scanning. MCC containing BubR1DLL:Bub3 is less efficient in inhibiting APC/C
cyclin B ubiquitination activity in comparison to MCC containing BubR1wt:
Bub3. Omitting Bub3 from MCC also reduces APC/C inhibition. NTD, N-ter-
minal domain; Ub, ubiquitin.
See also Figures S6 and S7.identical retention volumes in size exclusion chromatography
experiments, attesting to their stability (Figure S7B). BubR1WT:
Bub3, BubR1B1-LL:Bub3, and BubR1DLL:Bub3 also formed
stoichiometric MCC complexes with Cdc20 and Mad2 with
indistinguishable retention volumes (Figures 5A and S7B). We
used a recently described in vitro assay to monitor assembly2922 Current Biology 27, 2915–2927, October 9, 2017kinetics of MCC complexes containing BubR1B1-LL:Bub3 and
BubR1DLL:Bub3 [31] and found them to be identical to those of
BubR1WT:Bub3 (Figure S6C). Collectively, these observations
indicate that the BubR1 loop is dispensable for MCC stability
and assembly kinetics.
Therefore, we next tested the ability of MCC containing
either BubR1WT:Bub3 or BubR1DLL:Bub3 to inhibit APC/C activ-
ity in vitro by evaluating ubiquitination of the APC/C substrate
cyclin B. For these assays, we used concentrations of MCC
(30 nM), APC/C (20 nM), and Cdc20 (100 nM) that are considered
physiological [31]. To obtain active APC/C, we used APC/C-pE,
an APC/C mutant carrying 68 phosphomimetic mutations that
activate APC/C [70]. Wild-type and mutant MCC complexes
were allowed to assemble for 15 hr and were purified to homo-
geneity (Figure S6D). They were then added to APC/CCdc20
(besides being an MCC subunit, Cdc20 also acts as an activator
of APC/C), and the cyclin B ubiquitination reaction was initiated
by addition of the E1 ubiquitin mix. Under these conditions, we
observed near complete ubiquitination of cyclin B already within
30 min (Figure 5B, lanes 2–4). There was substantial inhibition of
this reaction upon addition of wild-type MCC, which continued
well into the 120 min time point (Figure 5B, lanes 5–7). MCC
containing BubR1DLL:Bub3, on the other hand, clearly retained
partial functionality but inhibited the cyclin B ubiquitination
activity of APC/C less efficiently than the wild-type complex (Fig-
ure 5B; compare lanes 5–7 with lanes 8–10).
These observations argue that removal of the loop region of
BubR1 causes a partial impairment of the ability of MCC to
inhibit APC/C. Because our previous studies argue the loop re-
gion of Bub1 acts to modulate the binding affinity of Bub3 for
phosphorylated MELT repeats [60] and our data so far suggest
that this may hold true also for the BubR1 loop, we assembled
MCCs with BubR1WT or BubR1DLL that lacked bound Bub3
and purified them to homogeneity. Importantly, the absence
of Bub3 did not overtly impair MCC formation or stability (Fig-
ure S6D). Both MCC versions lacking Bub3 were less efficient
in inhibiting APC/C cyclin B ubiquitination activity than MCC
containing BubR1WT bound to Bub3 and showed an even
stronger defect than that of MCC containing BubR1DLL:Bub3
(Figure 5B, lanes 11–16).
Bub3 Is Required for Robust SAC Signaling
Collectively, these results show that Bub3 plays a role in
APC/C inhibition and support the hypothesis that the BubR1
loop contributes to the regulation of this process. To test
directly the role of Bub3 in MCC function, we examined the
effects on the SAC of expressing BubR1 mutants impaired in
their interaction with Bub3. Specifically, we deleted the com-
plete B3BD (BubR1DB3BD) or introduced two point mutations
in the B3BD that are known to prevent Bub3 binding
(BubR1E409K+E413K; Figure 6A) [40, 42]. Both mutants were
unable to support the SAC in the absence of endogenous
BubR1 (Figure 6B). Furthermore, BubR1 mutants defective in
Bub3 binding were impaired in binding to APC/C subunits in
IPs, similar to the BubR1DLL mutant (Figure 6C; quantified
in Figure 6D). Collectively, our data provide a strong indication
that Bub3, in complex with BubR1, plays a role in the SAC and
that the BubR1 loop region works by modulating the inter-




Figure 6. Bub3 Is Required for Robust SAC Signaling
(A) Domain organization of the BubR1 constructs used.
(B) Mean duration of mitosis of Flp-In T-REx stable cell lines expressing the
indicated GFP-BubR1 constructs in the absence of endogenous BubR1 and in
the presence of 50 nM nocodazole. Cell morphology was used to measure
entry into and exit from mitosis by time-lapse microscopy (n > 55 per cell line
per experiment) from two independent experiments. Error bars depict SEM.
(C) Western blot of IPs from mitotic Flp-In T-REx cell lines expressing the
indicated GFP-BubR1 constructs showing a defect especially in binding to
APC/C subunits if BubR1 cannot bind to Bub3. Tubulin was used as loading
control. *, band resulting from previous incubation with Bub1 antibody; **,
unspecific band recognized by the Bub1 antibody.
(D) Quantification of the western blot in Figure 6C. The amounts of co-
precipitating proteins were normalized to the amount of GFP-BubR1 bait
present in the IPs. Values for GFP-BubR1wt are set to 1. The graph shows
mean intensity of two independent experiments. Error bars represent SEM.
See also Figure S4.DISCUSSION
BubR1 is an essential component of the SAC effector, the MCC.
Our understanding of the function of BubR1 in the SAC has been
greatly facilitated by functional and structural studies on the
MCC and of its interaction with APC/C. High-resolution struc-
tures of the APC/CMCC complex [43, 46, 47] have offered an ideal
framework to understand the molecular basis of the interaction
of MCC with the APC/C, including the role of specific BubR1
sequences identified in previous studies [71], such as the
KEN1 and KEN2 boxes and the more recently identified ABBA
motifs [3, 39, 41–44, 72–77]. The overall picture emerging
from these analyses is that a MCC core complex containing
one copy each of BubR1, Bub3, Cdc20, and Mad2 binds a sec-
ond Cdc20 molecule, possibly already bound to the APC/C
[2, 44–47]. In the APC/CMCC complex, BubR1 binds extensively
to both Cdc20 subunits, stabilizes the interaction of Mad2 with
one of the two Cdc20 subunits, and provides extensive contacts
with the APC/C that reinforce its interaction with MCC [46, 47].
The SAC role of Bub3, a constitutive binding partner of BubR1
and Bub1, has remained more elusive. In most organisms, Bub3
forms constitutive complexes both with Bub1 and with BubR1
[57]. An exception is Schizosaccharomyces pombe, where the
BubR1 ortholog Mad3 does not interact with Bub3 [43, 78].
The Bub1 and BubR1 paralogs perform distinct functions and
have distinct localization patterns. Ablation of Bub3 affects the
function of both paralogs, introducing a significant complication
in the interpretation of the resulting mitotic defect. On the other
hand, preventing the selective interaction of Bub1 or BubR1
with Bub3 by introducing point mutations in the Bub3 binding
domains of Bub1 or BubR1 lends itself to the objection that these
mutations, by disrupting an interaction with Bub3, might desta-
bilize MCC or its interaction with the APC/C. To overcome these
limitations, we took advantage of our previous structural anal-
ysis of the Bub1:Bub3:MELTP ternary complex, which identified
Bub3 as a phospho-amino acid adaptor and suggested that a
region of Bub1, the loop, contributes to the binding affinity for
phosphorylated targets [58]. Modifications of the Bub1 loop pre-
dictably alter the function of associated Bub3 [60], providing for
the first time a clean handle to distinguish the mitotic functions of
Bub1-associated andBubR1-associated Bub3without a need to
ablate Bub3 or its interactions with Bub1 or BubR1. In this study,
we have taken advantage of this recent progress to test the roleCurrent Biology 27, 2915–2927, October 9, 2017 2923
Figure 7. Model for the Differential Functions of the BubR1 andBub1
Loop
Model showing the different functions of the loops in BubR1 and Bub1. Bub1
and BubR1 form a pseudo-symmetric heterodimer through the B3BDs and
the helix as well as through the presence of Bub3. The loops are not involved
in this interaction but serve different functions. The Bub1 loop enhances
binding of the Bub1:Bub3 complex to Knl1-MELTP motifs, which in turn re-
cruits BubR1:Bub3 to kinetochores. The BubR1 loop, however, is not able to
enhance such an interaction of Bub3 with Knl1 but instead seems to promote
binding of BubR1:Bub3 to the APC/C. This is required for the SAC function of
BubR1. We hypothesize that this interaction could work via modulation of
Bub3 and be regulated in a phosphorylation-dependent manner, arguing that
the BubR1 loop functions in analogy to the Bub1 loop.of the BubR1 loop and discovered that it is essential for SAC
function. Thus, our analysis identifies another short, crucial
sequence determinant of BubR1 function in the SAC response.
Previously, it was proposed that Bub3 acts as a catalytic
enhancer of the BubR1:Cdc20 interaction at kinetochores and
in the cytosol [77]. The moderate stimulation by Bub3 of MCC-
dependent APC/C inhibition was interpreted in light of this
possible catalytic effect of Bub3 [77]. This alternative hypothesis,
however, is at odds with our recent demonstration that the
interaction of Mad2 with Cdc20 is the sole rate-limiting step of
MCC assembly [31].
Our interpretation of the role of Bub3 is rather that it contrib-
utes, thanks to modulation by the BubR1 loop motif, to the bind-
ing affinity of theMCC for the APC/C. Recombinant loopmutants
(BubR1B1-LL and BubR1DLL) engaged in stable MCC complexes
with Mad2, Cdc20, and Bub3 in vitro, which assembled with
rates identical to those observed with wild-type BubR1. Thus,
it is unlikely that the SAC defect observed with these mutants
reflects a problem in MCC assembly. In vitro cyclin B ubiquitina-
tion assays showed that BubR1 lacking the loop is less efficient
in inhibiting APC/C than BubR1WT, and this correlates with a loss
of APC/C binding affinity in vivo. Two Bub3-binding defective
BubR1 mutants (BubR1DB3BD and BubR1E409K+E413K) showed
the same SAC defect phenotype described for the loopmutants.
Their binding to APC/C subunits in coIPs was also impaired.
Phosphorylation of a loop of Apc1 promotes binding of Cdc20
andAPC/Cactivation [70, 79–84]. Similarly, phosphorylationmay
regulate SAC-dependent inhibition of APC/C. Bub3 is an adaptor
protein for phosphorylated motifs, and in complex with Bub1
(through the contribution of the Bub1 loop), it binds to phosphor-
ylatedMELT repeats of Knl1 [58, 60]. In analogy to the Bub1 loop,2924 Current Biology 27, 2915–2927, October 9, 2017we suspect that the BubR1 loop contributes to the recognition of
a phosphorylatedmotif on theAPC/CbyBub3 (Figure 7) [2]. Bub3
(with the help of the BubR1 loop) might be expected to bind
sequences related to theMELTPmotifs of Knl1. Two suchmotifs,
with sequencesMEVT andMELT, exist, respectively, in the Apc4
(residues 116–119) and Apc5 (residues 175–178) subunits of the
APC/C, and at least T178Apc5 is phosphorylated during mitosis
[70]. Furthermore, T178Apc5 and S179Apc5 are part of the pool of
putative phosphomimetic mutations in the APC/C pE sample.
We created a new APC/C mutant (APC/C pE-3A; Figure S6D)
carrying alanine mutations at T119Apc4, T178Apc5, and S179Apc5
and askedwhethermutation of these putative Bub3 targetmotifs
in APC/C weakened the sensitivity of APC/C to wild-type MCC,
phenocopying the removal of the BubR1 loop. However, APC/C
pE-3A remained as sensitive to MCC as APC/C pE, suggesting
that phosphorylation of these residues is not important for MCC
inhibition or that the penetrance of the phosphomimetic muta-
tions is limited (Figure S6E).
The identification of the relevant phospho-epitopes and of
the kinase that generates them is therefore an important priority
for future studies. Likely, this will be a challenging task, because
the 1.2-MDa APC/C particle is highly phosphorylated in mitosis
by several kinases, including Plk1 and Cdk1 [81, 85]. Further-
more, the structural analysis of the APC/CMCC complex offers
only limited insight into this specific question, because both
Bub3 and the segment of BubR1 that binds to it (the B3BD)
were invisible in the structures of APC/CMCC [46, 47].
Our analysis of the role of the BubR1 and Bub1 loop led us to
revisit the issue of themolecular basis of kinetochore localization
and turnover of Bub1 and BubR1. The main conclusions from
this analysis are completely consistent with the model that the
B3BD of Bub1 is sufficient for kinetochore localization, whereas
that of BubR1 is not. Our analysis tested all major predictions of
the model, providing a complete account of the mechanism of
Bub1 and BubR1 recruitment to kinetochores. It has recently
been proposed that a small autonomous pool of BubR1 can
localize to kinetochores in a Bub1-independent fashion to
perform its function in the SAC [86]. However, we suspect that
this pool of kinetochore BubR1 results from the availability of a
high concentration of free MELTP motifs after artificial Bub1
depletion [60, 86]. We show here that BubR1 mutants deprived
of the helical domain that mediates robust kinetochore recruit-
ment of BubR1 are SAC proficient and that further mutation of
the loop disrupts this SAC function. Finally, the BubR1 loop dele-
tion mutants we have tested localize normally to kinetochores
but are entirely SAC defective, clearly showing that the delete-
rious effects of loop mutations on the SAC are uncorrelated
with kinetochore localization of BubR1. In certain organisms,
like C. elegans and S. cerevisiae, the BubR1 ortholog Mad3
may not even be able to localize to kinetochores [62, 87]. The sig-
nificance of kinetochore recruitment of BubR1 remains therefore
an open question for future studies.
In conclusion, our studies illustrate how the divergence of two
paralogs resulted in the emergence of motifs that modulate the
binding affinity of a phosphopeptide-recognition module to allow
binding to distinct binding partners, a vivid example of sub-func-
tionalization. The evolutionary forces that drove the specific
sub-functionalization of Bub andMad proteins, however, remain
uncertain [88] and an interesting subject for future studies.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
cDNAs used for expression of recombinant proteins were either of human origin, or generated synthetically based on human
sequences. HeLa (female Cervix Adenocarcinoma) cells were grown in DMEM (PANBiotech) supplemented with 10% FBS, penicillin
and streptomycin and 2 mM L-glutamine. Cells were grown in a humidified atmosphere of 37C and 5% CO2.
METHOD DETAILS
Mammalian plasmids
Plasmids were derived from the pCDNA5/FRT/TO-EGFP-IRES, a previously modified version [5] of the pCDNA5/FRT/TO vector
(Invitrogen). To create N-terminally tagged EGFP Bub1 and BubR1 truncation constructs, Bub1 and BubR1 sequences were
obtained by PCR amplification from the previously generated pCDNA5/FRT/TO-EGFP-Bub1-IRES and pCDNA5/FRT/TO-EGFP-
BubR1-IRES vector, respectively [5] and subcloned in frame with the GFP-tag. Mutations and deletions within the Bub1 and
BubR1 constructs were generated by standard site-directed mutagenesis or by a mutagenesis protocol [92]. All Bub1 constructs
were RNAi resistant [6]. BubR1-expressing constructs were made siRNA-resistant by changing the sequence targeted by the
RNAi oligos to ‘AACGTGCCTTCGAGTACGAGA’. pCDNA5/FRT/TO-based plasmids were used for generation of stable cell lines,
as well as for transient transfection. All plasmids were verified by sequencing.
Cell culture and transfection
HeLa cells were grown in DMEM (PAN Biotech) supplemented with 10% FBS (Clontech), penicillin and streptomycin (GIBCO) and
2 mM L-glutamine (PAN Biotech). For all plasmid transfections of HeLa cells X-tremeGENE transfection agent (Roche) was used
at a 3:1 ratio with plasmid DNA. Flp-In T-REx HeLa cells used to generate stable doxycycline-inducible cell lines were a gift from
S.S. Taylor (University of Manchester, Manchester, England, UK). Flp-In T-REx host cell lines were maintained in DMEM with
10% tetracycline-free FBS (Clontech) supplemented with 50 mg/ml Zeocin (Invitrogen). Flp-In T-REx HeLa expression cell lines
were generated as previously described [5]. Briefly, Flp-In T-Rex HeLa host cells were cotransfected with a ratio of 9:1 (w/w)
pOG44:pcDNA5/FRT/TO expression plasmid using X-tremeGene transfection agent (Roche). 48 hr after transfection, Flp-In T-Rex
HeLa expression cell lines were put under selection for two weeks in DMEM with 10% tetracycline-free FBS (Invitrogen) supple-
mented with 250 mg/ml Hygromycin (Roche) and 5 mg/ml Blasticidin (ICN Chemicals). The resulting foci were pooled and tested
for expression. Gene expression was induced by addition of 0.05-0.5 mg/ml doxycycline (Sigma) for 24 hr. siBUB1 (GE Healthcare
Dharmacon; 50-GGUUGCCAACACAAGUUCU-30) or siBUBR1 (GE Healthcare Dharmacon; 50-CGGGCAUUUGAAUAUGAAA-30)
duplexes were transfected with Lipofectamine 2000 (Invitrogen) at 50 nM for 24 hr.
For experiments in HeLa cells, cells were synchronized with a double thymidine arrest 5 hr after transfection with siRNA duplexes.
In brief, after washing the cells with PBS they were treated with thymidine for 16 hr and then released into fresh medium. 3 hr after the
release, 50 nM siRNA duplexes were transfected for a second time. 5 hr after transfection, cells were treated with thymidine for 16 hr
and afterward released in fresh medium. Thymidine (Sigma-Aldrich) was used at 2 mM. Unless differently specified, nocodazole
(Sigma-Aldrich) was used at 3.3 mM.
Immunoprecipitation and immunoblotting
To generate mitotic populations for immunoprecipitation experiments, cells were treated with 330 nM nocodazole for 16 hr. Mitotic
cells were then harvested by shake off and lysed in lysis buffer [150 mM KCl, 75 mM HEPES, pH 7.5, 1.5 mM EGTA, 1.5 mMMgCl2,
10% glycerol, and 0.075% NP-40 supplemented with protease inhibitor cocktail (Serva) and PhosSTOP phosphatase inhibitors
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(Protein G affinity resin; Amintra) beads for 1 hr at 4C. Subsequently, extracts were incubated with GFP-Traps (ChromoTek; 3 ml/mg
of extract) for 3 hr at 4C. Immunoprecipitates were washed with lysis buffer and resuspended in sample buffer, boiled, and analyzed
by SDS-PAGE and western blotting using 4%–12% gradient gels (NuPAGE Bis-Tris Gels, Life technologies). For Cdc27 IPs, cells
were lysed in lysis buffer (described above) and extracts were precleared with protein G-agarose beads for 1 hr at 4C. Afterward,
extracts were incubated with 1.5 ug/mg of the anti-Cdc27 primary antibody (mouse monoclonal, BD) for 2 hr at 4C. Subsequently,
protein G-agarose beads were added for 4 hr at 4C. Immunoprecipitates were washed with a mild wash buffer (lysis buffer without
salt) and analyzed as described above. The following antibodies were used: anti-GFP (in house made rabbit polyclonal anti-
body; 1:1000-3000), anti-Knl1-N (in house made rabbit polyclonal SI0787 antibody; 1:1000), anti-Bub1 (rabbit polyclonal; Ab-
cam; 1:5000), anti-BubR1 (mouse monoclonal; BD; 1:1000), anti-BubR1 (sheep polyclonal, 1:500, a gift from S. S. Taylor (University
of Manchester, Manchester, England, UK)), anti-Bub3 (mouse monoclonal; BD; 1:1000), anti-Tubulin (mouse monoclonal; Sigma;
1:8000), anti-Apc7 (in house made rabbit polyclonal antibody SI0651, 1:500), anti-Apc4 (goat polyclonal, Santa-Cruz, 1:100), anti-
Cdc20 (mouse monoclonal, Santa Cruz, 1:500), anti-Mad2 (in house made mouse monoclonal antibody, clone AS55-A12, 1:500),
anti-Cdc27 (mouse monoclonal, BD; 1:1000-3000), anti-Vinculin (mouse monoclonal, Sigma, 1:20000). Secondary antibodies
were anti–mouse (Amersham), anti-goat (Santa-Cruz) and anti–rabbit (Amersham) affinity-purified with horseradish peroxidase con-
jugate (working dilution 1:10000) or Protein G with horseradish peroxidase conjugate (Life technologies) (working dilution 1:8000).
After incubation with ECL western blotting system (GE Healthcare), images were acquired with the ChemiDocTMMP Imaging System
(BioRad) in 16-bit TIFF format. Images were cropped and converted to 8-bit using ImageJ software (NIH). Brightness and contrast
were adjusted using Photoshop CS5 (Adobe). Unmodified 16-bit TIFF images were used for quantification with ImageJ software.
Measurements were graphed with Excel (Microsoft) and GraphPad Prism version 6.0 for Mac OS X (GraphPad Software).
SILAC and mass spectrometry
For labeling, cells were cultivated for five passages in specialized SILAC medium (DMEM, E15-086, PAA; dialyzed serum, A11-107,
PAA) supplemented with either ‘‘light’’ arginine and lysine (referred to as Arg-0 and Lys-0, A6969 and L8662, Sigma) or ‘‘heavy’’ argi-
nine (13C6
15N4) and lysine (
13C6
15N2) (referred to as Arg-10 and Lys-8) [68, 93]. Afterward, cells were synchronized in prometaphase
by the addition of 330 nM nocodazole for 16 hr and harvested by mitotic shake off. During the following anti-GFP IP (described in
immunoprecipitation and immunoblotting) the washing steps were performed in a mild wash buffer (75 mM HEPES, pH 7.5,
1.5 mM EGTA, 1.5 mM MgCl2, 10% glycerol) to preserve potentially weak interactions. IPs were usually performed in duplicates
swapping the labels (called FOR and REV) and repeated three times to be able to perform statistical analyses of the results. The cor-
responding heavy and light samples of the forward and reverse experiment were mixed in the last washing step. Afterward, samples
were processed for mass spectroscopy. Briefly, samples were reduced, alkylated, digested directly on the beads with LysC/Trypsin
and desalted/concentrated on C18-reversed phase stage tips. Samples were then separated on a Thermo Fisher ScientificTM EASY-
nLC 1000 HPLC system using a two hour gradient from 5%–60%with 0.1% formic acid and directly sprayed via a nanoelectrospray
ion source (Proxeon Biosystems, now Thermo Fisher Scientific) in a quadrupole Orbitrap mass spectrometer (Q ExactiveTM, Thermo
Fisher Scientific). The Q ExactiveTM was operated in a data dependent mode acquiring one survey scan and subsequently ten
MS/MS scans [94]. Data were analyzed with the quantitative proteomics software MaxQuant (version 1.5.2.18) [90] and further pro-
cessed in Perseus (version 1.5.1.5) [91]. Contaminants and reverse hits were removed from the protein lists. For t tests and volcano
plots, proteins were further filtered to be quantified in at least 2 out of 3 replicates.
Live cell imaging
Cells were plated on a 24-well m-Plate (Ibidi). Drugs were diluted in CO2 Independent Medium (GIBCO) and added to the cells 1 hr
before filming. Cells were imaged every 20 to 30 min in a heated chamber (37C) on a 3i Marianas system (Intelligent Imaging Inno-
vations Inc.) equipped with Axio Observer Z1 microscope (Zeiss), Plan-Apochromat 40x/1.4NA oil objective, M27 with DIC III Prism
(Zeiss), Orca Flash 4.0 sCMOS Camera (Hamamatsu) and controlled by Slidebook Software 6.0 (Intelligent Imaging Innovations Inc).
For cells expressing theGFP-BubR1 proteins, only cells in which kinetochores were visible (or that were GFP-positive - for constructs
that do not localize to kinetochores) were considered for the analysis.
Fluorescence recovery after photobleaching
For FRAP experiments cells were grown in 35 mm glass bottom m-dishes (Ibidi). Experiments were performed in the presence of
3.3 mM nocodazole, the presence of the GFP-tagged wild-type or mutant fusionprotein and in the absence of the endogenous pro-
tein. Cells were imaged on a 3iMarianas system (Intelligent Imaging Innovations Inc., described above) using a 100x/1.4NAOil Objec-
tive (Zeiss). Photobleaching was performed as described previously [95]. Briefly, individual kinetochores were bleached with 100%
laser power of an Argon-488 laser line. Images were binned 2x2 to increase signal-over-camera noise. At each time point a z stack
consisting of 3 sections at 0.27 mm intervals was acquired. The GFP-signal was imaged for 5 time frames before photobleaching.
After opening the laser shutter for 5 ms, cells were imaged by time-lapse microscopy, taking a z series every 0.8 s for a total duration
of 2min with an exposure time of 125ms. Imageswere converted intomaximal intensity projections and exported as 16-bit TIFF files.
Measurements of fluorescence intensity were made on the 16-bit maximal intensity projections using ImageJ. Apart from the
bleached KT, a non-bleached KT from the same nucleus and a region of the same size outside of the cell were also measured.
Afterward, measurements were exported into excel. The relative fluorescence intensity was calculated as RFI = (FROI(t)/FBG(t)) /
(FROI(t0)/FBG(t0)), as also described in [96], to correct for background intensity and for photobleaching that occurred during imagee5 Current Biology 27, 2915–2927.e1–e7, October 9, 2017
acquisition. FROI(t) is the intensity of the bleached KT at different time points after bleaching, FBG(t) is the intensity of the control non-
bleached KT at the corresponding time points. FROI(t0) is the average intensity of the bleached KT before bleaching, FBG(t0) is the
average intensity of the control non-bleached KT before bleaching. A baseline value, calculated from the region outside of the
cell, was subtracted from all values before entering the values into the formula shown above. The final data were analyzed using
Graph Pad Prism 6.0. Between 5 and 20 cells from at least two independent experiments were analyzed for each investigated
construct.
Immunofluorescence
HeLa cells and Flp-In T-REx HeLa cells were grown on coverslips precoated with poly-D-Lysine (Millipore, 15 mg/ml) and poly-L-
Lysine (Sigma), respectively. For the experiments with HeLa cells, cells were synchronized with a double thymidine block and after
release from that arrested in prometaphase by the addition of 330 nM nocodazole for 3 hr. For all other experiments, asynchronously
growing cells were arrested in prometaphase by the addition of nocodazole for 3-4 hr and fixed using 4% paraformaldehyde. Cells
were stained for Bub1 (mouse, ab54893, 1:400) and CREST/anti-centromere antibodies (Antibodies, Inc., 1:100), diluted in 2%BSA-
PBS for 1.5 hr. Goat anti–human Alexa Fluor 647 (Invitrogen) and goat anti–mouse RRX (Jackson ImmunoResearch Laboratories,
Inc.) were used as secondary antibodies. DNA was stained with 0.5 mg/ml DAPI (Serva) and coverslips were mounted with Mowiol
mounting media (Calbiochem). Cells were imaged at room temperature using a spinning disk confocal device on the 3i Marianas
system equipped with an Axio Observer Z1 microscope (Zeiss), a CSU-X1 confocal scanner unit (Yokogawa Electric Corporation),
Plan-Apochromat 63x or 100x/1.4NAOil Objectives (Zeiss) and Orca Flash 4.0 sCMOSCamera (Hamamatsu). Images were acquired
as z sections at 0.27 mm. Images were converted into maximal intensity projections, exported, and converted into 8-bit. Quantifica-
tion of kinetochore signals was performed on unmodified 16-bit z series images using Imaris 7.3.4 32-bit software (Bitplane). After
background subtraction, all signals were normalized to CREST. At least 307 kinetochores were analyzed per condition. Measure-
ments were exported in Excel (Microsoft) and graphed with GraphPad Prism 6.0 (GraphPad Software).
Protein expression and purification
Sequences coding for H6-mTurquoise-BubR11-571-DLL and H6-mTurquoise-BubR11-571-B1-LL were sub-cloned into pFLMultiBac
vectors and baculoviruses were generated [97]. Expression of H6-mTurquoise-BubR11-571, the BubR1 mutant constructs, untagged
Bub3, and Mps1 was performed in TnaO38 insect cells. Expression of H6-3xMyc-and BUB1:BUB3 was carried out in Sf9 cells.
Expression of H6-Mad2 was carried out in Escherichia coli [97]. After infection with virus (1:50), cultures were grown at 27C degrees
and harvested after three days, and pellets stored at 20C. MAD1:C-MAD2 and BUBR1:BUB3 were cultured by mixing individual
viruses, each harboring individual genes. MPS1 was expressed in the presence of 2 mM Reversine. Insect cells were harvested by
centrifugation at 750 g for 12min in a Sorvall RC3BP+ (Thermo Scientific) centrifuge with Rotor H6000A. The pellet was resuspended
in PBS, centrifuged at 500 g for 5 min, the supernatant was discarded and the pellet was stored at 20C.
Generally, the cell pellet from 1 l of insect cell culture volume was re-suspended in 250 mL lysis buffer (25 mM HEPES pH 7.5,
300 mM NaCl, 5% glycerol, 10 mM imidazole, 1 mM TCEP, 1 mM PMSF). Cdc20 was purified in lysis buffer with 500 mM NaCl. Cells
were lysed by sonication and centrifuged at 108000 g (Rotor JA30.50, Avanti-J30I, Beckman Coulter) for 30 min at 4C. The super-
natant was filtered through 0.8 mmRotilabo syringe filters (Carl Roth GmbH). The proteins were isolated from the cleared lysate on a
5 mL HisTrap FF affinity column (GE Healthcare). Peak fractions were pooled, concentrated, and further purified in gelfiltration buffer
(10 mM HEPES pH 7.5, 150 mM NaCl, 5% glycerol, 1 mM TCEP) by size exclusion chromatography on a S200 16/60 column
(GE Healthcare). Peak fractions were pooled, concentrated to typically 3 to 5 mg/ml, flash frozen and stored at 80C until use.
For the purification of recombinant MCC complexes, individual purified MCC components were mixed to obtain 250 mg of MCC
and incubated at 4C over night. Afterward, gelfiltration was performed using a Superdex 200 increase 5/150 column (GEHealthcare)
equilibrated against a buffer containing 20 mM HEPES pH 7.5, 200 mM NaCl and 2 mM DTT. Peak fractions were pooled, concen-
trated flash frozen and stored at 80C.
Size-exclusion chromatography mobility shift assay
Proteins tested for interactions were diluted to a final concentration of 5 mM in 50 ml reactions in binding buffer (10mMHEPES pH 7.5,
150 mM NaCl, 5% glycerol, 1 mM TCEP, 1 mM MgCl2) and incubated at 4
C over night. Complex formation was analyzed by size
exclusion chromatography on a Superdex 200 increase 5/150 column (GE Healthcare). Eluates were analyzed by SDS-PAGE and
Coomassie staining.
MCC assembly kinetics
The assay was performed precisely as described [31]. Fluorimeter scans were performed on a Fluoromax 4 (Jobin Yvon) in a buffer
containing fresh 10 mM HEPES (pH 7.5), 150 mM NaCl, 2.5% glycerol, 10 mM beta-mercaptoenthanol and 0.05% Triton X-100.
Mixtures were excited at 430 nm and the emissions were scanned from 450 to 650 nm. Single wavelength acceptor fluorescence
measurements were carried out at 583 nm. Mixtures of MAD1:C-MAD2 with BUB1:BUB3 and/or MPS1 were pre-incubated at
1 mM for 30 min at 30 degrees. Assays were performed using 100 nM of all proteins, except CDC20, which was added at 500 nM.
Curves reporting time-dependent changes in FRET signal report single measurements representative of at least three independent
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APC/C-mediated ubiquitination assays
To measure the activity of APC/C, its ability to form poly-ubiquitin chains on its substrate Cyclin B was analyzed. Recombinant
APC/C-pE, containing 68 phospho-mimicking mutations [70], was used as mimic of mitotic APC/C. APC/C-pE (20 nM) and
Cdc20 (100 nM) were part of a mastermix with 500 nM CycBNTD*, 500 nM UbcH10, 500 nM Ube2S, 2.5 mM MgATP and
0.5 mg/ml BSA. This was aliquoted and mixed with recombinant MCC versions (30 nM) on ice. Reactions were equilibrated to
room temperature for 10 min and afterward started by the addition of the Uba1 (100 nM)/Ub (100 mM) mix. After 30, 60 and
120 min reactions were stopped by the addition of SDS sample buffer. Samples were analyzed by SDS-PAGE and fluorescence
scanning.
QUANTIFICATION AND STATISTICAL ANALYSES
For FRAP experiments, statistical analysis is described in the Figure legends, in the Method Details, and in Table S1. For kinetochore
localization experiments and checkpoint assays, quantification and statistical analysis (mean ± SEM) are described in the figure leg-
ends. Quantification and statistical analysis of immunoprecipitation experiments (mean ± SEM) are described in the figure legends.
Analysis of SILAC data is described in the Methods details.
DATA AND SOFTWARE AVAILABILITY
The full list of interacting proteins identified in the SILAC experiments is available with the online version of the paper as Data S1.e7 Current Biology 27, 2915–2927.e1–e7, October 9, 2017
